Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphosphate SCHEMBL454437 | 0.90 | FDPS (0.41) | FDPSBLMTDP1 | |
| Pyrimidine SCHEMBL4140225 | 0.88 | FDPS (0.39) | FDPSBLMTDP1 | |
| Pyrimidine SCHEMBL27738489 | 0.86 | FDPS (0.38) | FDPSBLMTDP1 | |
| Pyrophosphoric Acid SCHEMBL1333626 | 0.84 | FDPS (0.53) | FDPSBLMTDP1SRC | |
| Pyrophosphoric Acid SCHEMBL1334782 | 0.84 | FDPS (0.53) | FDPSBLMTDP1SRC | |
| Pyrophosphoric Acid SCHEMBL1357468 | 0.84 | FDPS (0.53) | FDPSBLMTDP1SRC | |
| Pyrophosphoric Acid SCHEMBL31722246 | 0.84 | FDPS (0.53) | FDPSBLMTDP1SRC | |
| Pyrophosphoric Acid SCHEMBL5997484 | 0.83 | FDPS (0.59) | FDPSBLMTDP1 | |
| Pyrimidine SCHEMBL988740 | 0.83 | FDPS (0.34) | FDPSTDP1 | |
| Pyrimidine SCHEMBL454436 | 0.83 | FDPS (0.34) | FDPSTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12480144-B2 | Cannabinoid synthase variants and methods for their use | CREO INGREDIENTS, INC. (US) | 2025-11-25 | — | — | US | claimed |
| US-20230167468-A1 | CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE | CREO INGREDIENTS, INC. | 2023-06-01 | — | — | US | claimed |
| EP-4136220-A1 | CANNABINOID SYNTHASE VARIANTS AND METHODS FOR THEIR USE | Genomatica, Inc. (US) | 2023-02-22 | — | — | EP | claimed |
| US-20230037234-A1 | ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-CoA-DERIVED PRODUCTS | AGAIN BIO APS (DK) | 2023-02-02 | — | — | US | claimed |
| EP-4065717-A1 | ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-COA-DERIVED PRODUCTS | Genomatica, Inc. (US) | 2022-10-05 | — | — | EP | claimed |
| CN-103031286-B | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2015-03-18 | — | — | CN | claimed |
| CN-103031287-B | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2014-12-10 | — | — | CN | claimed |
| CN-103045548-A | Cordyceps sinensis ribonucleotide reductase as well as coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-17 | — | — | CN | claimed |
| CN-103031286-A | Cordyceps Chinese Hirsutella uridylate-cytidylate kinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-10 | — | — | CN | claimed |
| CN-103031287-A | Cordyceps Chinese Hirsutella nucleoside diphosphokinase, coding gene and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2013-04-10 | — | — | CN | claimed |
| US-7612047-B2 | Degradation-resistant mononucleoside phosphate compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 2009-11-03 | — | — | US | claimed |
| US-20090076256-A1 | DEGRADATION-RESISTANT MONONUCLEOSIDE PHOSPHATE COMPOUNDS | DOUGLASS III JAMES G | 2009-03-19 | — | — | US | claimed |
| US-20250388874-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | GENOMATICA INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12480144-B2 | Cannabinoid synthase variants and methods for their use | CREO INGREDIENTS, INC. (US) | 2025-11-25 | — | — | US | disclosed |
| US-20250290048-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | CREO INGREDIENTS, INC. | 2025-09-18 | — | — | US | disclosed |
| US-20250171813-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | CREO INGREDIENTS, INC. | 2025-05-29 | — | — | US | disclosed |
| CN-1217003-C | Micro array reaction apparatus and uses thereof | CAPTIAL BIOCHIP CO LTD (CN) | 2005-08-31 | — | — | CN | disclosed |
| WO-2005070088-A2 | CHIMERIC SEQUENCES FOR TISSUE-SPECIFIC GENE EXPRESSION IN PLANTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005001101-A1 | CONDITIONAL STERILITY IN PLANTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| US-6512164-B1 | Thiamine biosynthetic enzymes | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388874-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | BLVRB, SQOR, CYP2F1 | FDPS 28/4885BLM 1808/4885TDP1 946/4885 |
| US-20090076256-A1 | DEGRADATION-RESISTANT MONONUCLEOSIDE PHOSPHATE COMPOUNDS | PNKP, ENTPD5, ENPP1 | FDPS 184/4885BLM 454/4885TDP1 489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.